NNECOS Research Funding Grants

Student-Led Research Grants Also Available!

Summer Cycle Application Deadline is July 15th

Completed applications should be submitted via email to

info@nnecos.org no later than July 15th.

2019 Research Proposal Call for Proposals and Application Template


Call for Proposals

The Northern New England Clinical Oncology Society is seeking research funding proposals for investigative projects of value to the entire Northern New England community of cancer care providers. The society seeks to award one or more research grants to worthy proposals, up to a total of $20,000. Eligible candidates will be a current NNECOS member in good standing. Projects should be in alignment with the society’s mission to assure access to high quality oncology care in our region. Preference will be given to projects promoting collaboration amongst NNECOS institutions (academic and community). Fellows and others are strongly encouraged to apply. 

Proposal Elements

Proposals should satisfy the following criteria:

    1. Introduction:  Describes the problem and data supporting development of the research question. The introduction should be limited to 1-2 paragraphs.
    2. Objectives: Propose clearly defined objectives and describe what specific measures will be used to determine if objective is satisfied. There should be a limited number of objectives with one primary objective.
    3. Methods: Describe actions to be taken and the rationale for the application of specific procedures or techniques.
    4. Statistics: Except for small pilot/feasibility studies, statistics should be provided to support sample sizes.
    5. Budget:The budget must be clearly outlined. Indirect costs and salary support for academic attending physicians and private practice providers should not be included in a budget. Materials and funds for services of collaborating facility employees required in the operations of a project (i.e. research coordinator, statistician, etc. in alignment with national averages for their role) are examples of items to include in the budget. If the proposal is part of a larger project, the total amount of funding and its sources should be disclosed.
    6. References: Pertinent journal and abstract references to support proposal should be provided.
    7. Total Length: The introduction, objectives, methods and statistics sections should cover no more than 2 pages in length.

    Notification

    Awardees will be notified in approximately 30 days, be required to submit progress reports to NNECOS, and may be asked to present a final report of the research to the NNECOS annual meeting.

    APPLICATION DEADLINE
    !
    Completed applications must be received via email no later than 11:59pm on July 15, 2019.


    Since the program’s inception in 2008, the NNECOS Research Funding Program has awarded more than $135,000 to worthy projects of value to the Northern New England region.

    Congratulations to the 2017 NNECOS Research Grant Recipients

    NNECOS awarded a total of $45,694 in research grants to 2017 applicants

    Cycle 2


      

    • DNA repair landscape of discordant sibling pairs from hereditary breast cancer families, Kara Landry, MD, Larner College of Medicine, University of Vermont
    • Assessing the Utility of Predictive Early Chimerism Analysis Following Haploidentical Stem Cell
      Transplant
      , Raphael Lizcano, MD, Dartmouth-Hitchcock/White River Junction, VA

    Cycle 1


    • Pilot Study involving Active Surveillance with CT Imaging and Liquid Biopsies for Inoperable Stage IA Lung Cancer in the Elderly, Christopher Anker, MD, University of Vermont Medical Center
    • Use of a toxicity assessment questionnaire to evaluate clinical significance of the statin paclitaxel drug interaction, Michael Pelchat, RPh, NH Oncology-Hematology
    Congratulations to 2011 NNECOS Research Grant recipient, Ivette Emery, PhD on publication of your study results in the Journal of Neuro-oncology!  https://link.springer.com/article/10.1007/s11060-017-2422-z


    Past Projects Funded Include:

    • Clinical Trial Barrier Study
      • Assessment of perceived cost to the patient and other barriers to clinical trial participation. Weckstein DJ, Thomas CA, Emery IF, Shea BF, Fleury A, White ME, Chase E, Robinson C, Frazier S, Pilar C. J Oncol Pract. 2011 Sep;7(5):33

    • Exercise for Individuals with Stage IV Cancer
      • Litterini A, Cavanaugh J, Fieler V, Lee JQ.  Differential Effects of Cardiovascular and Resistance Exercise on Functional Mobility in Individuals with Advanced Cancer: A Randomized Trial. Arch Phys Med Rehabil. 2013;94:2329-35.

      • Litterini, A and Lee, J. “Exercise for Individuals with Metastatic Cancer.” APTA 2013 Combined Sections Meeting, Oncology Section Platform Presentation, San Diego, CA, 2013.

      • Litterini, A., and Fieler, V. “Differential Effects of Cardiovascular and Resistance Exercise on Functional Mobility in Individuals with Advanced Cancer: A Randomized Trial.” Poster Presentation, 2015 New England Cancer Survivorship Research Symposium, Harvard Medical School/ Dana-Farber Cancer Institute in Boston, MA, on April 2, 2015. Available [on-line]: http://dune.une.edu/pt_facpost/4

    • Head and neck cancer trial involving response to neoadjuvant chemotherapy
    Role of prostaglandin pathways in radiotherapy-induced mucositis.
    Steven M. Grunberg, Madhuri V. Vithala, Margaret Vizzard, Nathan Bradley Adams, Havaleh Marie Gagne, William Brundage, and Takamaru Ashikaga; Journal of Clinical Oncology 2013 31:15_suppl, e20509-e20509
    • Inhibition of stem cell pathways in a patient-derived GBM tumor model system.
    • Emery, Ivette et al.  Expression and Function of ABCG2 and XIAP in Glioblastomas. Journal of NeuroOncology May 2017. Volume 133(1) 47-57
    • Coagulation activation in brain neoplasms
        • Coagulation Activation in Brain Neoplasms, Swaroopa Yerrabothala, Brett L. Gourley, James C Ford, Syed Rakin Ahmed, Stephen J Guerin, Heather A Wishart, Camilo E Fadul and Deborah L. Ornstein; Blood 2017 130:3704; http://www.bloodjournal.org/content/130/Suppl_1/3704
        • DNA repair landscape in individuals with increased risk of breast cancer
          • Curtis, Adam & Rueter, Jens & Rajan, Shelia & Zhang, Rong & Shopland, Lindsay. (2018). Additive and synergistic inhibition of mantle cell lymphoma cell growth by combining olaparib with ibrutinib. Journal of Cellular Biochemistry. 119. 10.1002/jcb.26773. Download this paper. 
          • Poster at 2017 NNECOS Annual Meeting.
        • Social Media Usage within the Cancer Community of Northern New England
        • Thrombin Generation as a Predictive Biomarker for Venous thromboembolism in Patients with Pancreatic and Lung Cancer Undergoing Chemotherapy
        • Synergistic targeting of CLL cells with DNA repair and B cell receptor inhibitors - view the poster
        • Pilot study of the role of MDSCs and VISTA in immunology of chronic graft-versus-host disease following reduced intensity allogeneic bone marrow transplantation
        • Pilot Study involving Active Surveillance with CT Imaging and Liquid Biopsies for Inoperable Stage IA Lung Cancer in the Elderly
        • Use of a toxicity assessment questionnaire to evaluate clinical significance of the statin paclitaxel drug interaction
        • DNA repair landscape of discordant sibling pairs from hereditary breast cancer families
        • Assessing the Utility of Predictive Early Chimerism Analysis Following Haploidentical Stem Cell
          Transplant



        Northern New England Clinical Oncology Society
        P.O. Box 643
        Sandown, NH 03873-0643
        Telephone (603) 887-1948
        info@nnecos.org

        This website brought to you by:


        Powered by Wild Apricot Membership Software